by webmaster | Sep 12, 2022 | News en
The idea for Sensidose’s treatment strategy came about already in the mid-1990s when professors Sten-Magnus Aquilonius and Christer Nyström realized that it would be possible to personalise Parkinson’s treatment with microtablets. Today, the company’s drug Flexilev... by webmaster | Sep 6, 2022 | News en
Pharma company Sensidose has recruited Philip Slätis as Chief Operating Officer and Deputy CEO. Slätis takes on on his role on November 1 and brings broad experience from the pharmaceutical industry. He is expected to contribute to the company’s business development... 
by webmaster | Sep 1, 2022 | News en
Sollentuna 1:a September 2022 Sensidose reinforces its management. Philip Slätis has been hired as Chief Operating Officer and Deputy CEO of Sensidose AB. Philip will take up the position on 1st November in 2022. – Philips’ broad experience from all parts... 
by webmaster | Aug 26, 2022 | News en
Sensidose recently reported an increase in net sales of 21 per cent for the second quarter compared to the same period in 2021. At the same time as the company is growing, they have also made progress during the quarter in the development of the new dosing device,... 
by webmaster | Mar 10, 2022 | News en
Sensidose will participate at the BioStock Investor Meeting on March 16. The presentation starts at 14:05. Follow the event online here: https://youtu.be/tv-ZDUn3zzI #Sensidose #BioStockSWE #investormeeting... 
by webmaster | Aug 19, 2019 | News en
Sensidose AB (the “Company”) has entered into a service agreement with Desitin Arzneimittel GmbH (“Desitin”) for the sales and marketing of Flexilev (under the trade name Suades) in Germany. Sensidose and Desitin will share the revenue from the... 
by webmaster | Mar 20, 2019 | News en
Sensidose receives SEK 1.22 million in grants from Vinnova for industrial research within the call “Innovation projects in companies”. The funding aims to support the company’s development of measuring physiological reactions to pain to enable... 
by webmaster | Aug 27, 2018 | News en
Sensidose participated in the Swedish-American Life Science Summit (SALSS) between the 22nd to 24th of August 2018 in Stockholm, Sweden. The summit is a by-invitation-only conference bringing together some of the most renowned Life Science executives, scientists,... 
by webmaster | Jun 15, 2018 | News en
The Annual General Meeting was held on May 29 at the company’s premises in Sollentuna. The chairman of the meeting was elected lawyer Mikael Smedeby from Lindahl’s law firm. At the annual meeting, Gunnar Säll, after 5 years as the chairman resigned.... 
by webmaster | Apr 6, 2018 | News en
Sensidose has strengthened its market with the employment of Pontus Salomonsson, who takes the role of sales and marketing manager . Pontus comes departed from Grünenthal where he was the head of Parkinson in the Nordic region. Prior to that, he has worked at Lundbeck...